Investing.com - MorphoSys ADR reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
MorphoSys ADR announced earnings per share of $3.60 on revenue of $85.8M. Analysts polled by Investing.com anticipated EPS of $-0.50 on revenue of $60.3M.
MorphoSys ADR shares are down 59.02% from the beginning of the year, still down 65.10% from its 52 week high of $11.06 set on November 16, 2021.
MorphoSys ADR follows other major Healthcare sector earnings this month
MorphoSys ADR's report follows an earnings beat by J&J on October 18, who reported EPS of $2.55 on revenue of $23.79B, compared to forecasts EPS of $2.48 on revenue of $23.36B.
Eli Lilly had beat expectations on November 1 with third quarter EPS of $1.98 on revenue of $6.94B, compared to forecast for EPS of $1.91 on revenue of $6.91B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar